English and Italian speakers with dementia-related language impairment experience distinct kinds of speech and reading difficulties based on features of their native languages, according to new research by scientists at the UC San Francisco Memory and Aging Center and colleagues at the Neuroimaging Research Unit and Neurology Unit at the San Raffaele Scientific Institute in Milan.
Neurologists had long assumed that brain diseases that impact language abilities would manifest in essentially the same way in patients around the world. But recent discoveries have begun to question that assumption. For instance, Italian speakers with dyslexia tend to have less severe reading impairment than English or French speakers due to Italian’s simpler and more phonetic spelling.
“Clinical criteria for diagnosing disorders that affect behavior and language are still mainly based on studies of English speakers and Western cultures, which could lead to misdiagnosis if people who speak different languages or come from another cultural background express symptoms differently,” said study senior author Maria Luisa Gorno-Tempini, MD, PhD, a professor of neurology and psychiatry and the Charles Schwab Distinguished Professor in Dyslexia and Neurodevelopment at the UCSF Memory and Aging Center. “It is critical going forward that studies take language and cultural differences into account when studying brain disorders that affect higher cognitive functions — which we know are greatly impacted by culture, environment, and experience.”
The new study, published January 10, 2020 in Neurology, the medical journal of the American Academy of Neurology, focused on patients with primary progressive aphasia (PPA), a neurodegenerative disorder that affects language areas in the brain, a condition often associated with Alzheimer’s disease, frontotemporal lobar degeneration, and other dementia disorders.
The researchers recruited 20 English-speaking PPA patients from the UCSF Memory and Aging Center and 18 Italian-speaking PPA patients from San Raffaele Hospital, all of whom shared a variant of PPA characterized by difficulty producing or pronouncing words — so-called non-fluent PPA.
“We wanted to study patients with PPA to understand whether people from different language backgrounds actually experienced the disease differently, and what that might mean for how we try to help patients remain resilient to the disease,” said study lead author Elisa Canu, PhD, a neuropsychologist and researcher in the San Raffaele Scientific Institute’s Neuroimaging Research Unit, which is led by co-author Massimo Filippi, MD, full professor of neurology at the affiliated Vita-Salute San Raffaele University, and director of the neurology and neurophysiology units at the San Raffaele Hospital.
Cognitive tests and MRI brain scans revealed similar cognitive function and comparable levels of brain degeneration in the two groups. But when the researchers compared their performance on a battery of linguistic tests, they observed a key difference.
English speakers had more trouble pronouncing words — the traditional hallmark of nonfluent PPA — and tended to speak less than usual. In contrast, Italian speakers with the same disorder had fewer pronunciation difficulties but tended to produce much shorter and grammatically simpler sentences. For example, when asked to describe a drawing of a family at a lake house picnicking and flying a kite, Italian speakers with non-fluent PPA might respond (in Italian): “The man and the woman and the dog”; “Boat in the water”; “Family have picnic”; “There is a kite”.
“We think this is specifically because the consonant clusters that are so common in English pose a challenge for a degenerating speech-planning system,” said Gorno-Tempini, who directs the language neurobiology laboratory at the UCSF Memory and Aging Center, and is co-director of the UCSF Dyslexia Center and the recently launched UCSF-UC Berkeley Schwab Dyslexia and Cognitive Diversity Center. “In contrast, Italian is easier to pronounce, but has much more complex grammar, and this is how Italian speakers with PPA tend to run into trouble."
The results are important for efforts to ensure accurate diagnoses for patients with PPA across different cultures: in the current study the Italian speakers do not match the established diagnostic criteria for nonfluent PPA as closely as the English speakers, since the criteria are based on studies of English-speaking patients.
“This means that there are probably many people around the world — including non-native English speakers in the U.S. — who are not getting the right diagnosis because their symptoms don’t match what is described in clinical manuals based on studies of native English speakers,” said Gorno-Tempini.
The researchers acknowledge that this is a small study and cannot completely exclude the possibility that differences in dementia severity, undetected anatomical differences and differences in education level between Italian and English participants could be confounding factors in the results.
Future studies in partnership with the Global Brain Health Institute (GBHI), a joint effort of UCSF and Trinity College Dublin to reduce the impact of dementia around the world, will attempt to replicate the findings in larger groups of patients, and look for further differences between speakers of even more diverse, non-Western languages, such as Chinese and Arabic.
“We hope that such studies will advance our understanding of the brain science underlying language and language disorders, raise awareness of health disparities in dementia treatment, and ultimately improve care for all patients,” Gorno-Tempini said.
Authors: Maria Luisa Gorno-Tempini, MD, PhD, is the study’s senior author. Gorno-Tempini is a professor of neurology and psychiatry and the Charles Schwab Distinguished Professor in Dyslexia and Neurodevelopment at the UCSF Memory and Aging Center, director of the UCSF Memory and Aging Center language neurobiology laboratory, founding co-director of the UCSF Dyslexia Center and co-director of the UCSF-UC Berkeley Schwab Dyslexia and Cognitive Diversity Center. Elisa Canu, PhD, of the San Raffaele Scientific Institute in Milan is the study’s lead and corresponding author. Canu is a researcher in the San Raffaele Scientific Institute’s Neuroimaging Research Unit, which is led by co-author Massimo Filippi, MD, full professor of neurology at the affiliated Vita-Salute San Raffaele University, Director of the Neurology and Neurophysiology Units at the San Raffaele Hospital.
See study online for full list of authors.
Funding: This study has been supported by the US National Institutes of Health (NINDS R01 NS050915; NIDCD K24 DC015544; NIAU01 AG052943; NIA P50 AG023501; NIA P01 AG019724), the Italian Ministry of Health (GR-2010-2303035; GR-2011-02351217), the Alzheimer’s Disease Center of California (03-75271 DHS/ADP/ARCC), the Larry L. Hillblom Foundation, the John Douglas French Alzheimer’s Foundation, the Koret Family Foundation, the Consortium for Frontotemporal Dementia Research, and the McBean Family Foundation.
Disclosures: See study online for listing of potential conflict of interest disclosures.
The University of California, San Francisco (UCSF) is exclusively focused on the health sciences and is dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. UCSF Health, which serves as UCSF’s primary academic medical center, includes top-ranked specialty hospitals and other clinical programs, and has affiliations throughout the Bay Area.